Pharmaceutical intermediates
Nebivolol Hydrochloride Intermediates
4 pharmaceutical intermediates for Nebivolol Hydrochloride. Indication: Hypertension.
About Nebivolol Hydrochloride
- Originator
- Johnson & Johnson Innovation Pharmaceuticals
- Indication
- Hypertension
- Approved Date
- 01/01/1997
Available intermediates
4 intermediates currently listed for Nebivolol Hydrochloride. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| (±)-(R*, R* und R*, S*)-6-Fluoro-3,4-dihydro-2-oxiranyl-2H-1-benzopyran | 129050-26-6 | / | / |
| (2S, 2’S)-6-Fluoro-2-(2’-oxiranyl)chromane | 129050-23-3 | / | / |
| (+)-(S,R)-6-fluoro-3,4-dihydro-2-(2-oxiranyl)-2H-1-benzopyran | 197706-51-7 | / | / |
| (R)-6-Fluoro-2-[(R)-2-oxiranyl]chromane | 197706-50-6 | / | / |
Other programs under N
Building toward Nebivolol Hydrochloride?
Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.
How can we help you?
Receive insights into the latest events and regulatory updates
Sent directly to your email
Get industry insights and Unibest news here
Contact Us →